, Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique, F-69677

, Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, F-69372

N. Département-de, Groupe Hospitalier Pitié-Salpêtrière, 75013

. Service-de-neurologie, CSF inflammation was significantly more frequent in LE/-and LE/+ patients (14/17, 82.4%

, All but 1 of the sera tested for CASPR2-Ab (n=52: 16 LE, vol.9, p.11

, Among all tested CSF, 31/48 (64.6%) samples were positive for CASPR2-Ab. CSF detection rates of CASPR2-Ab did not differ between LE/-and LE/+ groups (16/18 vs. 11/11, p=0.5)

P. Pnh/-and and . Patients, detection of CASPR2-Ab in CSF was significantly more frequent in LE patients than in those from both the PNH

, /12, p=3.4x10 -8 ) groups. In addition, CASPR2-Ab were more commonly found in the CSF of PNH

, Serum LGI1-Ab were only detected in PNH/+ patients (10/15, 66.7%, p=2x10 -6 ) and only in those with malignant thymoma (10/13 vs. 0/37, p=2.7x10 -8 ), PNH/-patients who had overlapping PNH and limbic features

, belonging to a patient of the PNH/+ group. Serum was still available for the establishment of CASPR2-Ab end-point dilution for 43 patients, 02%) was positive at very low titers (end-point dilution, 1:20), vol.9

G. R. Anderson, T. Galfin, W. Xu, J. Aoto, R. C. Malenka et al., Candidate Autism Gene Screen Identifies Critical Role for Cell-Adhesion Molecule CASPR2 in Dendritic Arborization and Spine Development, Proceedings of the National Academy of Sciences of the United States of America, vol.109, issue.44, pp.18120-18145, 2012.

H. Ariño, R. Höftberger, N. Gresa-arribas, E. Martínez-hernández, T. Armangue et al., Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies, JAMA Neurology, vol.72, issue.8, pp.874-81, 2015.

. Bakkaloglu, B. J. Betul, A. O'roak, A. R. Louvi, J. F. Gupta et al., Molecular Cytogenetic Analysis and Resequencing of Contactin Associated Protein-like 2 in Autism Spectrum Disorders, American Journal of Human Genetics, vol.82, issue.1, pp.165-73, 2008.

B. Balint, S. Jarius, S. Nagel, U. Haberkorn, C. Probst et al., Progressive Encephalomyelitis with Rigidity and Myoclonus: A New Variant with DPPX Antibodies, Neurology, vol.82, issue.17, pp.1521-1549, 2014.

B. Balint, J. U. Regula, S. Jarius, and B. Wildemann, Caspr2 Antibodies in Limbic Encephalitis with Cerebellar Ataxia, Dyskinesias and Myoclonus, Journal of the Neurological Sciences, vol.327, issue.1-2, pp.73-74, 2013.

R. W. Baloh, Episodic Ataxias 1 and 2, Handbook of Clinical Neurology, vol.103, pp.595-602, 2012.

L. Bataller, G. Kleopa, J. Wu, M. Rossi, J. R-rosenfeld et al., Autoimmune Limbic Encephalitis in 39 Patients: Immunophenotypes and Outcomes, Neurosurgery, and Psychiatry, vol.78, issue.4, pp.381-85, 2007.

E. B. Becker, L. Zuliani, R. Pettingill, B. Lang, P. Waters et al., Contactin-Associated Protein-2 Antibodies in Non-Paraneoplastic Cerebellar Ataxia, Neurosurgery & Psychiatry, vol.83, issue.4, pp.437-477, 2012.

C. Bel, K. Oguievetskaia, C. Pitaval, L. Goutebroze, and C. Faivre-sarrailh, Axonal Targeting of Caspr2 in Hippocampal Neurons via Selective Somatodendritic Endocytosis, Journal of Cell Science, vol.122, pp.3403-3416, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417338

C. G. Bien, Z. Mirzadjanova, C. Baumgartner, M. D. Onugoren, T. Grunwald et al., Anti-Contactin-Associated Protein-2 Encephalitis: Relevance of Antibody Titres, Presentation and Outcome, European Journal of Neurology, vol.24, issue.1, pp.175-86, 2017.

C. G. Bien, A. Vincent, M. H. Barnett, A. J. Becker, I. Blümcke et al., Immunopathology of Autoantibody-Associated Encephalitides: Clues for Pathogenesis, Brain: A Journal of Neurology, vol.135, pp.1622-1660, 2012.

C. I. Bindon, G. Hale, M. Brüggemann, and H. Waldmann, Human Monoclonal IgG Isotypes Differ in Complement Activating Function at the Level of C4 as Well as C1q, The Journal of Experimental Medicine, vol.168, issue.1, pp.127-169, 1988.

S. N. Binks, J. Christopher, P. Klein, S. J. Waters, S. R. Pittock et al., LGI1, CASPR2 and Related Antibodies: A Molecular Evolution of the Phenotypes, Neurosurgery, and Psychiatry, vol.89, issue.5, pp.526-560, 2018.

S. Binks, J. Varley, W. Lee, M. Makuch, K. Elliott et al., Distinct HLA Associations of LGI1 and CASPR2-Antibody Diseases, Brain, vol.141, issue.8, pp.2263-71, 2018.

G. Bonetto, B. Hivert, L. Goutebroze, and D. Karagogeos, Selective Axonal Expression of the Kv1 Channel Complex in Pre-Myelinated GABAergic Hippocampal Neurons, Frontiers in Cellular Neuroscience, vol.13, p.222, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02351141

A. Bourquin, M. Süveges, M. Pertin, N. Gilliard, S. Sardy et al., Assessment and Analysis of Mechanical Allodynia-like Behavior Induced by Spared Nerve Injury (SNI) in the Mouse, Pain, vol.122, issue.1-2, pp.14-15, 2006.

D. L. Browne, S. T. Gancher, J. G. Nutt, E. R. Brunt, E. A. Smith et al., Episodic Ataxia/Myokymia Syndrome Is Associated with Point Mutations in the Human Potassium Channel Gene, KCNA1, Nature Genetics, vol.8, issue.2, pp.136-176, 1994.

P. Bruhns, B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez et al., Specificity and Affinity of Human Fcgamma Receptors and Their Polymorphic Variants for Human IgG Subclasses, Blood, vol.113, issue.16, pp.3716-3741, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00363931

E. D. Buttermore, L. Jeffrey, J. Dupree, X. Cheng, L. An et al., The Cytoskeletal Adaptor Protein Band 4.1B Is Required for the Maintenance of Paranodal Axoglial Septate Junctions in Myelinated Axons, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol.31, issue.22, pp.8013-8037, 2011.

G. Canali, M. Garcia, B. Hivert, D. Pinatel, A. Goullancourt et al., Genetic Variants in Autism-Related CNTNAP2 Impair Axonal Growth of Cortical Neurons, Human Molecular Genetics, vol.27, issue.11, pp.1941-54, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01963618

N. Chen, F. Koopmans, A. Gordon, I. Paliukhovich, R. V. Klaassen et al., Interaction Proteomics of Canonical Caspr2 (CNTNAP2) Reveals the Presence of Two Caspr2 Isoforms with Overlapping Interactomes, Biochimica Et Biophysica Acta, vol.1854, issue.7, pp.827-860, 2015.

C. Cifuentes-diaz, F. Chareyre, M. Garcia, J. Devaux, M. Carnaud et al., Protein 4.1B Contributes to the Organization of Peripheral Myelinated Axons, PloS One, vol.6, issue.9, p.25043, 2011.

M. H. Coevorden-hameete, . Van, A. A. Marienke, E. De-bruijn, D. A. De-graaff et al., The Expanded Clinical Spectrum of Anti-GABABR Encephalitis and Added Value of KCTD16 Autoantibodies, Brain: A Journal of Neurology, vol.142, issue.6, pp.1631-1674, 2019.

J. R. Cornelius, J. Sean, A. Pittock, V. A. Mckeon, P. A. Lennon et al., Sleep Manifestations of Voltage-Gated Potassium Channel Complex Autoimmunity, Archives of Neurology, vol.68, issue.6, pp.733-771, 2011.

J. A. Corsellis, G. J. Goldberg, and A. R. Norton, Limbic Encephalitis' and Its Association with Carcinoma, Brain, vol.91, issue.3, pp.481-96, 1968.

J. Crawley and F. K. Goodwin, Preliminary Report of a Simple Animal Behavior Model for the Anxiolytic Effects of Benzodiazepines, Pharmacology, Biochemistry, and Behavior, vol.13, issue.2, pp.167-70, 1980.

M. D'adamo, S. Cristina, L. Hasan, I. Guglielmi, M. Servettini et al., New Insights into the Pathogenesis and Therapeutics of Episodic Ataxia Type 1, Frontiers in Cellular Neuroscience, vol.9, p.317, 2015.

J. Dalmau and F. Graus, Antibody-Mediated Encephalitis, New England Journal of Medicine, vol.378, issue.9, pp.840-51, 2018.

J. Dalmau, F. Graus, A. Villarejo, B. Jerome, D. Posner et al., Clinical Analysis of Anti-Ma2-Associated Encephalitis, Brain: A Journal of Neurology, vol.127, pp.1831-1875, 2004.

J. Dalmau, E. Lancaster, E. Martinez-hernandez, M. R. Rosenfeld, and R. Balice-gordon, Clinical Experience and Laboratory Investigations in Patients with Anti-NMDAR Encephalitis, Lancet Neurology, vol.10, issue.1, pp.63-74, 2011.

J. Dalmau, E. Tüzün, H. Wu, J. Masjuan, J. E. Rossi et al., Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated with Ovarian Teratoma, Annals of Neurology, vol.61, issue.1, pp.25-36, 2007.

J. M. Dawes, G. A. Weir, S. J. Middleton, R. Patel, K. I. Chisholm et al., Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability, Neuron, vol.97, issue.4, pp.806-822, 2018.

N. Denisenko-nehrbass, K. Oguievetskaia, and L. Goutebroze,

H. Galvez, O. Yamakawa, M. Ohara, J. Carnaud, and . Girault, Protein 4.1B Associates with Both Caspr/Paranodin and Caspr2 at Paranodes and Juxtaparanodes of Myelinated Fibres, The European Journal of Neuroscience, vol.17, issue.2, pp.411-427, 2003.

. Do, E. Le-duy, V. Chanson, B. Desestret, F. Joubert et al., Characteristics in Limbic Encephalitis with Anti-Adenylate Kinase 5 Autoantibodies, Neurology, vol.88, issue.6, pp.514-538, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02095555

A. Duflocq, F. Chareyre, M. Giovannini, F. Couraud, and M. Davenne, Characterization of the Axon Initial Segment (AIS) of Motor Neurons and Identification of a Para-AIS and a Juxtapara-AIS, Organized by Protein 4.1B, BMC Biology, vol.9, p.66, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00634721

A. Ennaceur, One-Trial Object Recognition in Rats and Mice: Methodological and Theoretical Issues, Behavioural Brain Research, vol.215, issue.2, pp.244-54, 2010.

D. Fernandes, S. D. Santos, E. Coutinho, J. L. Whitt, N. Beltrão et al., Disrupted AMPA Receptor Function upon Genetic-or Antibody-Mediated Loss of Autism-Associated CASPR2, Cerebral Cortex, 1991.

J. Fleisher, M. Richie, R. Price, S. Scherer, J. Dalmau et al., Acquired Neuromyotonia Heralding Recurrent Thymoma in Myasthenia Gravis, JAMA Neurology, vol.70, issue.10, pp.1311-1325, 2013.

M. Gastaldi, A. Rosa, M. Maestri, E. Zardini, S. Scaranzin et al., Acquired Neuromyotonia in Thymoma-Associated Myasthenia Gravis: A Clinical and Serological Study, European Journal of Neurology, vol.26, issue.7, pp.992-99, 2019.

M. Giannoccaro, D. A. Pia, L. Menassa, E. Jacobson, G. Coutinho et al., Behaviour and Neuropathology in Mice Injected with Human Contactin-Associated Protein 2 Antibodies, Brain: A Journal of Neurology, 2019.

A. Gordon, D. Salomon, N. Barak, Y. Pen, M. Tsoory et al., Expression of Cntnap2 (Caspr2) in Multiple Levels of Sensory Systems, Molecular and Cellular Neurosciences, vol.70, pp.42-53, 2016.

F. Gövert, K. Witt, R. Erro, H. Hellriegel, S. Paschen et al., Orthostatic Myoclonus Associated with Caspr2 Antibodies, Neurology, vol.86, issue.14, pp.1353-55, 2016.

E. R. Graf, X. Zhang, S. Jin, M. W. Linhoff, and A. M. Craig, Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins, Cell, vol.119, issue.7, pp.1013-1039, 2004.

F. Graus, F. Keime-guibert, R. Reñe, B. Benyahia, T. Ribalta et al., Anti-Hu-Associated Paraneoplastic Encephalomyelitis: Analysis of 200 Patients, Brain, vol.124, issue.6, pp.1138-1186, 2001.

. Graus, M. J. Francesc, R. Titulaer, S. Balu, C. G. Benseler et al., A Clinical Approach to Diagnosis of Autoimmune Encephalitis, The Lancet. Neurology, vol.15, issue.4, pp.391-404, 2016.

. Gresa-arribas, J. Nuria, M. Planagumà, I. Petit-pedrol, S. Kawachi et al., Human Neurexin-3?, 2016.

, Antibodies Associate with Encephalitis and Alter Synapse Development, Neurology, vol.86, issue.24, pp.2235-2277

S. Gultekin, M. R-rosenfeld, R. Voltz, J. Eichen, J. Posner et al., Paraneoplastic Limbic Encephalitis: Neurological Symptoms, Immunological Findings and Tumour Association in 50 Patients, Brain: A Journal of Neurology, vol.123, issue.7, pp.1481-94, 2000.

S. J. Guyenet, A. Stephanie, V. M. Furrer, T. D. Damian, and A. R. Baughan,

L. Spada and G. A. Garden, A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia, Journal of Visualized Experiments : JoVE, issue.39, 2010.

M. Hara, H. Ariño, M. Petit-pedrol, L. Sabater, J. Maarten et al., DPPX Antibody-Associated Encephalitis: Main Syndrome and Antibody Effects, Neurology, vol.88, issue.14, pp.1340-1388, 2017.

K. Hargreaves, R. Dubner, F. Brown, C. Flores, and J. Joris, A New and Sensitive Method for Measuring Thermal Nociception in Cutaneous Hyperalgesia, Pain, vol.32, issue.1, pp.77-88, 1988.

I. K. Hart, P. Maddison, J. Newsom-davis, A. Vincent, and K. R. Mills, Phenotypic Variants of Autoimmune Peripheral Nerve Hyperexcitability, Brain: A Journal of Neurology, vol.125, pp.1887-95, 2002.

H. Haselmann, F. Mannara, C. Werner, J. Planagumà, F. Miguez-cabello et al., Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction, Neuron, vol.100, issue.1, pp.91-105, 2018.

B. Hivert and L. Marien, ADAM22 and ADAM23 Modulate the Targeting of the Kv1 Channel-Associated Protein LGI1 to the Axon Initial Segment, Journal of Cell Science, vol.132, issue.2, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02061637

R. Höftberger, A. Van-sonderen, F. Leypoldt, D. Houghton, M. Geschwind et al., Encephalitis and AMPA Receptor Antibodies: Novel Findings in a Case Series of 22 Patients, Neurology, vol.84, issue.24, pp.2403-2415, 2015.

S. Holm, A Simple Sequentially Rejective Multiple Test Procedure, 1979.

, Scandinavian Journal of Statistics, vol.6, issue.2, pp.65-70

J. Honnorat, S. Cartalat-carel, D. Ricard, J. Camdessanche, A. F. Carpentier et al., Onco-Neural Antibodies and Tumour Type Determine Survival and Neurological Symptoms in Paraneoplastic Neurological Syndromes with Hu or CV2/CRMP5 Antibodies, Neurosurgery & Psychiatry, vol.80, issue.4, pp.412-428, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00321230

I. Horresh, V. Bar, J. L. Kissil, and E. Peles, Organization of Myelinated Axons by Caspr and Caspr2 Requires the Cytoskeletal Adapter Protein 4.1B, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol.30, issue.7, pp.2480-89, 2010.

I. Horresh, S. Poliak, S. Grant, D. Bredt, M. N. Rasband et al., Multiple Molecular Interactions Determine the Clustering of Caspr2 and Kv1 Channels in Myelinated Axons, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol.28, issue.52, pp.14213-14235, 2008.

M. G. Huijbers, W. Zhang, R. Klooster, E. H. Niks, M. B. Friese et al., MuSK IgG4 Autoantibodies Cause Myasthenia Gravis by Inhibiting Binding between MuSK and Lrp4, Proceedings of the National Academy of Sciences of the United States of America, vol.110, issue.51, pp.20783-88, 2013.

T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii et al., Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome without Tumor Removal, Neurology, vol.70, issue.7, pp.504-515, 2008.

M. Inda, J. Carmen, A. Defelipe, and . Muñoz, Voltage-Gated Ion Channels in the Axon Initial Segment of Human Cortical Pyramidal Cells and Their Relationship with Chandelier Cells, Proceedings of the National Academy of Sciences of the United States of America, vol.103, issue.8, pp.2920-2945, 2006.

S. R. Irani, S. Alexander, P. Waters, A. Kleopas, P. Kleopa et al., Antibodies to Kv1 Potassium Channel-Complex Proteins Leucine-Rich, Glioma Inactivated 1 Protein and Contactin-Associated Protein-2 in Limbic Encephalitis, Morvan's Syndrome and Acquired Neuromyotonia, Brain, vol.133, issue.9, pp.2734-2782, 2010.

S. R. Irani, P. Pettingill, A. Kleopas, N. Kleopa, P. Schiza et al., Morvan Syndrome: Clinical and Serological Observations in 29 Cases, Annals of Neurology, vol.72, issue.2, pp.241-55, 2012.

S. R. Irani, C. J. Stagg, J. M. Schott, C. R. Rosenthal, S. A. Schneider et al., Faciobrachial Dystonic Seizures: The Influence of Immunotherapy on Seizure Control and Prevention of Cognitive Impairment in a Broadening Phenotype, Brain, vol.136, issue.10, pp.3151-62, 2013.

J. C. Jen and J. Wan, Episodic Ataxias, Handbook of Clinical Neurology, vol.155, pp.205-220, 2018.

. Joubert, F. Bastien, and . Gobert,

P. Desestret, V. Convers, and . Rogemond, Autoimmune Episodic Ataxia in Patients with Anti-CASPR2 Antibody-Associated Encephalitis, Neurology: Neuroimmunology & Neuroinflammation, vol.4, issue.4, p.371, 2017.

. Joubert, P. Bastien, A. Kerschen, V. Zekeridou, V. Desestret et al., Clinical Spectrum of Encephalitis Associated With Antibodies Against the ?-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature, JAMA Neurology, vol.72, issue.10, pp.1163-69, 2015.

. Joubert, M. Bastien, N. Saint-martin, G. Noraz, V. Picard et al., Characterization of a Subtype of, Autoimmune Encephalitis With Anti-Contactin-Associated Protein, issue.2, 2016.

, Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures, vol.73, p.1115

T. Kim, S. Lee, J. Moon, J. Sunwoo, J. Byun et al., Anti-LGI1 Encephalitis Is Associated with Unique HLA Subtypes: HLA Subtypes in Anti-LGI1 Encephalitis, Annals of Neurology, vol.81, issue.2, pp.183-92, 2017.

C. J. Klein, A. Vanda, P. A. Lennon, A. Aston, . Mckeon et al., Insights from LGI1 and CASPR2 Potassium Channel Complex Autoantibody Subtyping, JAMA Neurology, vol.70, issue.2, pp.229-263, 2013.

K. A. Kleopa, B. Lauren, B. Elman, A. Lang, S. S. Vincent et al., Neuromyotonia and Limbic Encephalitis Sera Target Mature Shaker-Type K+ Channels: Subunit Specificity Correlates with Clinical Manifestations, Brain: A Journal of Neurology, vol.129, pp.1570-84, 2006.

M. König, A. M. Zimmer, H. Steiner, P. V. Holmes, J. N. Crawley et al., Pain Responses, Anxiety and Aggression in Mice Deficient in Pre-Proenkephalin, Nature, vol.383, issue.6600, pp.535-573, 1996.

P. Körtvelyessy, J. Bauer, C. M. Stoppel, W. Brück, I. Gerth et al., Complement-Associated Neuronal Loss in a Patient with CASPR2 Antibody-Associated Encephalitis, Neurology® Neuroimmunology & Neuroinflammation, vol.2, issue.2, p.75, 2015.

M. Lai, E. G. Hughes, X. Peng, L. Zhou, A. J. Gleichman et al., AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location, Annals of Neurology, vol.65, issue.4, pp.424-458, 2009.

M. Lai, G. Maartje, E. Huijbers, F. Lancaster, L. Graus et al., Investigation of LGI1 as the Antigen in Limbic Encephalitis Previously Attributed to Potassium Channels: A Case Series, Lancet Neurology, vol.9, issue.8, pp.776-85, 2010.

E. Lancaster, G. M. Maartje, V. Huijbers, A. Bar, A. Boronat et al., , 2011.

N. Autoantigen-of-encephalitis, Annals of Neurology, vol.69, issue.2, pp.303-314

B. Lang, M. Makuch, T. Moloney, I. Dettmann, S. Mindorf et al., Intracellular and Non-Neuronal Targets of Voltage-Gated Potassium Channel Complex Antibodies, Neurosurgery, and Psychiatry, vol.88, issue.4, pp.353-61, 2017.

V. Lange, I. Böhme, J. Hofmann, K. Lang, J. Sauter et al., Cost-Efficient High-Throughput HLA Typing by MiSeq Amplicon Sequencing, BMC Genomics, vol.15, issue.1, p.63, 2014.

B. Lanuzza, D. Aricò, F. I. Cosentino, F. Provini, and R. Ferri, Video-Polysomnographic Study of a Patient with Morvan's Fibrillary Chorea, Sleep Medicine, vol.13, issue.5, pp.550-53, 2012.

C. Laurencin, N. André-obadia, J. Camdessanché, F. Mauguière, E. Ong et al., Peripheral Small Fiber Dysfunction and Neuropathic Pain in Patients with Morvan Syndrome, Neurology, vol.85, issue.23, pp.2076-78, 2015.

R. Liguori, Morvan's Syndrome: Peripheral and Central Nervous System and Cardiac Involvement with Antibodies to Voltage-Gated Potassium Channels, Brain, vol.124, issue.12, pp.2417-2443, 2001.

C. Lombardi, M. F. Pengo, and G. Parati, Obstructive Sleep Apnea Syndrome and Autonomic Dysfunction, Autonomic Neuroscience, vol.221, p.102563, 2019.

Z. Lu, M. V. Sekhar-reddy, J. Liu, A. Kalichava, J. Liu et al., Molecular Architecture of Contactin-Associated Proteinlike 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2), The Journal of Biological Chemistry, vol.291, pp.24133-24180, 2016.

E. Lugaresi and F. Provini, Agrypnia Excitata: Clinical Features and Pathophysiological Implications, Sleep Medicine Reviews, vol.5, issue.4, pp.313-335, 2001.

E. Lugaresi, F. Provini, and P. Cortelli, Agrypnia Excitata, Sleep Medicine, vol.12, pp.3-10, 2011.

M. P. Malter, C. Frisch, J. C. Schoene-bake, C. Helmstaedter, K. P. Wandinger et al., Outcome of Limbic Encephalitis with VGKC-Complex Antibodies: Relation to Antigenic Specificity, Journal of Neurology, vol.261, issue.9, pp.1695-1705, 2014.

A. Maureille, T. Fenouil, B. Joubert, G. Picard, V. Rogemond et al., Isolated Seizures Are a Common Early Feature of Paraneoplastic Anti-GABAB Receptor Encephalitis, Journal of Neurology, vol.266, issue.1, pp.195-206, 2019.

A. Morvan and . Marie, Gazette Hebdomadaire de Médecine et de, Chirurgie, vol.27, issue.15, pp.173-76, 1890.

V. Navarro, A. Kas, E. Apartis, L. Chami, V. Rogemond et al., Motor Cortex and Hippocampus Are the Two Main Cortical Targets in LGI1-Antibody Encephalitis, Brain: A Journal of Neurology, vol.139, pp.1079-93, 2016.

N. Kolfschoten, J. Marijn-van-der, M. Schuurman, . Losen, K. Wim et al., Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange, Science, vol.317, issue.5844, pp.1554-57, 2007.

J. Newsom-davis and K. R. Mills, Immunological Associations of Acquired Neuromyotonia (Isaacs' Syndrome), Brain: A Journal of Neurology, vol.116, issue.2, pp.453-69, 1993.

A. S. Ng, J. Kramer, A. Centurion, J. Dalmau, E. Huang et al.,

. Cotter, D. Michael, and . Geschwind, Clinico-Pathological Correlation in Adenylate Kinase 5 Autoimmune Limbic Encephalitis, Journal of Neuroimmunology, vol.287, pp.31-35, 2015.

Y. Ogawa, I. Horresh, J. S. Trimmer, D. S. Bredt, E. Peles et al., Postsynaptic Density-93 Clusters Kv1 Channels at Axon Initial Segments Independently of Caspr2, The Journal of Neuroscience, vol.28, issue.22, pp.5731-5770, 2008.

Y. Ogawa and J. Oses-prieto,

J. S. Burlingame, D. Trimmer, M. N. Meijer, and . Rasband, ADAM22, a Kv1 Channel-Interacting Protein, Recruits Membrane-Associated Guanylate Kinases to Juxtaparanodes of Myelinated Axons, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol.30, issue.3, pp.1038-1086, 2010.

A. L. Olsen, Y. Lai, J. Dalmau, S. S. Scherer, and E. Lancaster, Caspr2 Autoantibodies Target Multiple Epitopes, Neurology® Neuroimmunology & Neuroinflammation, vol.2, issue.4, p.127, 2015.

E. Ong, A. Viaccoz, F. Ducray, M. Pérol, G. Cavillon et al., Dramatic Improvement after Rituximab in a Patient with Paraneoplastic Treatment-Refractory Morvan Syndrome Associated with Anti-CASPR2 Antibodies, European Journal of Neurology, vol.20, issue.7, pp.96-97, 2013.

S. V. Ovsepian, M. L. Volker-steuber, L. O. Berre, V. B. Hara, J. O'leary et al., A Defined Heteromeric KV1 Channel Stabilizes the Intrinsic Pacemaking and Regulates the Output of Deep Cerebellar Nuclear Neurons to Thalamic Targets, The Journal of Physiology, vol.591, issue.7, pp.1771-91, 2013.

R. W. Paterson, S. Michael, R. Zandi, A. Armstrong, and J. M. Vincent,

. Schott, Clinical Relevance of Positive Voltage-Gated Potassium Channel (VGKC)-Complex Antibodies: Experience from a Tertiary Referral Centre, Neurosurgery, and Psychiatry, vol.85, issue.6, pp.625-655, 2014.

K. R. Patterson, J. Dalmau, and E. Lancaster, Mechanisms of Caspr2 Antibodies in Autoimmune Encephalitis and Neuromyotonia, Annals of Neurology, vol.83, issue.1, pp.40-51, 2018.

K. Peeters, T. Chamova, I. Tournev, and A. Jordanova, Axonal Neuropathy with Neuromyotonia: There Is a HINT, Brain: A Journal of Neurology, vol.140, issue.4, pp.868-77, 2017.

. Petit-pedrol, T. Mar, X. Armangue, L. Peng, T. Bataller et al., Encephalitis with Refractory Seizures, Status Epilepticus, and Antibodies to the GABAA Receptor: A Case Series, Characterisation of the Antigen, and Analysis of the Effects of Antibodies, The Lancet. Neurology, vol.13, issue.3, pp.276-86, 2014.

. Petit-pedrol, J. Mar, J. Sell, F. Planagumà, M. Mannara et al., LGI1 Antibodies Alter Kv1.1 and AMPA Receptors Changing Synaptic Excitability, Plasticity and Memory, vol.141, pp.3144-59, 2018.

D. Pinatel, B. Hivert, J. Boucraut, M. Saint-martin, V. Rogemond et al., Inhibitory Axons Are Targeted in Hippocampal Cell Culture by Anti-Caspr2 Autoantibodies Associated with Limbic Encephalitis, Frontiers in Cellular Neuroscience, vol.9, p.265, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01201572

D. Pinatel, B. Hivert, M. Saint-martin, N. Noraz, M. Savvaki et al., The Kv1-Associated Molecules TAG-1 and Caspr2 Are Selectively Targeted to the Axon Initial Segment in Hippocampal Neurons, Journal of Cell Science, vol.130, issue.13, pp.2209-2229, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02322304

J. Planagumà, H. Haselmann, F. Mannara, M. Petit-pedrol, B. Grünewald et al., Ephrin-B2 Prevents N-Methyl-D-Aspartate Receptor Antibody Effects on Memory and Neuroplasticity, Annals of Neurology, vol.80, issue.3, pp.388-400, 2016.

J. Planagumà, F. Leypoldt, F. Mannara, J. Gutiérrez-cuesta, E. Martín-garcía et al., Human N-Methyl D-Aspartate Receptor Antibodies Alter Memory and Behaviour in Mice, Brain: A Journal of Neurology, vol.138, pp.94-109, 2015.

S. Poliak, L. Gollan, R. Martinez, A. Custer, S. Einheber et al., Caspr2, a New Member of the Neurexin Superfamily, Is Localized at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels, Neuron, vol.24, issue.4, pp.1037-1084, 1999.

S. Poliak, D. Salomon, H. Elhanany, H. Sabanay, B. Kiernan et al., Juxtaparanodal Clustering of Shaker-like K+ Channels in Myelinated Axons Depends on Caspr2 and TAG-1, The Journal of Cell Biology, vol.162, issue.6, pp.1149-60, 2003.

M. Poot, Intragenic CNTNAP2 Deletions: A Bridge Too Far?, Molecular Syndromology, vol.8, issue.3, pp.118-148, 2017.

R. D. Porsolt, A. Bertin, and M. Jalfre, Behavioral Despair in Mice: A Primary Screening Test for Antidepressants, Archives Internationales De Pharmacodynamie Et De Therapie, vol.229, issue.2, pp.327-363, 1977.

M. N. Rasband, E. W. Park, D. Zhen, M. I. Arbuckle, S. Poliak et al., Clustering of Neuronal Potassium Channels Is Independent of Their Interaction with PSD-95, The Journal of Cell Biology, vol.159, issue.4, pp.663-72, 2002.

J. Reeback, S. Benton, M. Swash, and M. S. Schwartz, Penicillamine-Induced Neuromyotonia, British Medical Journal, vol.1, issue.6176, pp.1464-65, 1979.

H. Reiber and P. Lange, Quantification of Virus-Specific Antibodies in Cerebrospinal Fluid and Serum: Sensitive and Specific Detection of Antibody Synthesis in Brain, Clinical Chemistry, vol.37, issue.7, pp.1153-60, 1991.

H. Roger, J. Alliez, and J. Roger, La Chorée Fibrillaire de Morvan Bilan de 70 Observations Dont 30 Personnelles, Revue Neurologique, vol.88, issue.3, pp.164-73, 1953.

E. N. Rubio-marrero, G. Vincelli, C. M. Jeffries, T. R. Shaikh, I. S. Pakos et al., Structural Characterization of the Extracellular Domain of CASPR2 and Insights into Its Association with the Novel Ligand Contactin1, The Journal of Biological Chemistry, vol.291, issue.11, pp.5788-5802, 2016.

L. Sabater, C. Gaig, E. Gelpi, L. Bataller, J. Lewerenz et al., A Novel Non-Rapid-Eye Movement and Rapid-Eye-Movement Parasomnia with Sleep Breathing Disorder Associated with Antibodies to IgLON5: A Case Series, Characterisation of the Antigen, and Post-Mortem Study, The Lancet. Neurology, vol.13, issue.6, pp.70051-70052, 2014.

L. Sabater, J. Planagumà, J. Dalmau, and F. Graus, Cellular Investigations with Human Antibodies Associated with the Anti-IgLON5 Syndrome, Journal of Neuroinflammation, vol.13, issue.1, p.226, 2016.

A. Sadnicka, M. M. Reilly, C. Mummery, S. Brandner, N. Hirsch et al., Rituximab in the Treatment of Three Coexistent Neurological Autoimmune Diseases: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Morvan Syndrome and Myasthenia Gravis, Neurosurgery, and Psychiatry, vol.82, issue.2, pp.230-262, 2011.

M. Saint-martin, A. Pieters, B. Déchelotte, C. Malleval, D. Pinatel et al., Impact of Anti-CASPR2 Autoantibodies from Patients with Autoimmune Encephalitis on CASPR2/TAG-1 Interaction and Kv1 Expression, Journal of Autoimmunity, 2019.

A. Saiz, Y. Blanco, L. Sabater, F. González, and L. Bataller, Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodies: Diagnostic Clues for This Association, Brain: A Journal of Neurology, vol.131, pp.2553-63, 2008.

L. H. Sansing, M. W. Erdem-tüzün, J. Ko, D. R. Baccon, J. Lynch et al., A Patient with Encephalitis Associated with NMDA Receptor Antibodies, Nature Clinical Practice. Neurology, vol.3, issue.5, pp.291-96, 2007.

K. Sawlani and B. Katirji, ) 23 (5, Peripheral Nerve and Motor Neuron Disorders, Continuum, pp.1437-50, 2017.

J. Schuurman, R. Van-ree, G. J. Perdok, H. R. Van-doorn, K. Y. Tan et al., Normal Human Immunoglobulin G4 Is Bispecific: It Has Two Different Antigen-Combining Sites, Immunology, vol.97, issue.4, pp.693-98, 1999.

R. Scott, A. Sánchez-aguilera, K. Van-elst, L. Lim, N. Dehorter et al., Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior, Cerebral Cortex, vol.29, issue.2, pp.586-97, 1991.

. Selimbeyoglu, C. K. Aslihan, M. Kim, . Inoue, A. S. Soo-yeun-lee et al., Modulation of Prefrontal Cortex Excitation/Inhibition Balance Rescues Social Behavior in CNTNAP2-Deficient Mice, Science Translational Medicine, vol.9, issue.401, 2017.

. Shillito, P. C. Paul, A. Molenaar, K. Vincent, W. Leys et al., Acquired Neuromyotonia: Evidence for Autoantibodies Directed against K+ Channels of Peripheral Nerves, Annals of Neurology, vol.38, issue.5, pp.714-722, 1995.

S. Sinha, J. Newsom-davis, K. Mills, N. Byrne, B. Lang et al., Autoimmune Aetiology for Acquired Neuromyotonia (Isaacs' Syndrome), Lancet, vol.338, issue.8759, pp.75-77, 1991.

A. V. Sonderen, H. Ariño, J. Dalmau, and M. J. Titulaer, Author Response: The Clinical Spectrum of Caspr2 Antibody-Associated Disease, Neurology, vol.88, issue.3, pp.333-367, 2017.

A. V. Sonderen, H. Ariño, M. Petit-pedrol, F. Leypoldt, P. Körtvélyessy et al., The Clinical Spectrum of Caspr2 Antibody-Associated Disease, Neurology, vol.87, issue.5, pp.521-549, 2016.

A. V. Sonderen, D. L. Roelen, J. A. Stoop, R. M. Verdijk, and W. Geert,

R. D. Haasnoot, P. W. Thijs, and . Wirtz, Anti-LGI1 Encephalitis Is Strongly Associated with HLA-DR7 and HLA-DRB4: Anti-LGI1 Encephalitis, Annals of Neurology, vol.81, issue.2, pp.193-98, 2017.

A. V. Sonderen, W. J. Marco, . Schreurs, A. A. Marienke, S. De-bruijn et al., The Relevance of VGKC Positivity in the Absence of LGI1 and Caspr2 Antibodies, 2016.

A. V. Sonderen, R. D. Thijs, E. C. Coenders, L. C. Jiskoot, E. Sanchez et al., Anti-LGI1 Encephalitis: Clinical Syndrome and Long-Term Follow-Up, Neurology, vol.87, issue.14, pp.1449-56, 2016.

M. Spatola, M. Petit-pedrol, M. M. Simabukuro, T. Armangue, F. J. Castro et al., Investigations in GABAA Receptor Antibody-Associated Encephalitis, Neurology, vol.88, issue.11, pp.1012-1032, 2017.

M. Spatola, L. Sabater, J. Planagumà, E. Martínez-hernandez, T. Armangué et al., Encephalitis with MGluR5 Antibodies: Symptoms and Antibody Effects, Neurology, vol.90, issue.22, pp.1964-72, 2018.

T. Strekalova, N. Gorenkova, E. Schunk, O. Dolgov, and D. Bartsch, Selective Effects of Citalopram in a Mouse Model of Stress-Induced Anhedonia with a Control for Chronic Stress, Behavioural Pharmacology, vol.17, issue.3, pp.271-87, 2006.

J. Sunwoo, S. Lee, J. Byun, J. Moon, J. Shin et al., Clinical Manifestations of Patients with CASPR2 Antibodies, Journal of Neuroimmunology, vol.281, pp.17-22, 2015.

G. Taglialatela, D. Hogan, W. Zhang, and K. T. Dineley, Intermediate-and Long-Term Recognition Memory Deficits in Tg2576 Mice Are Reversed with Acute Calcineurin Inhibition, Behavioural Brain Research, vol.200, issue.1, pp.95-99, 2009.

Y. Tanabe, E. Fujita-jimbo, M. Y. Momoi, and T. Momoi, CASPR2 Forms a Complex with GPR37 via MUPP1 but Not with GPR37(R558Q), an Autism Spectrum Disorder-Related Mutation, Journal of Neurochemistry, vol.134, issue.4, pp.783-93, 2015.

G. M. Terwindt, R. A. Ophoff, J. Haan, M. N. Vergouwe, R. Van-eijk et al., Variable Clinical Expression of Mutations in the P/Q-Type Calcium Channel Gene in Familial Hemiplegic Migraine. Dutch Migraine Genetics Research Group, Neurology, vol.50, issue.4, pp.1105-1115, 1998.

M. J. Titulaer, L. Mccracken, I. Gabilondo, T. Armangué, C. Glaser et al., Treatment and Prognostic Factors for Long-Term Outcome in Patients with Anti-NMDA Receptor Encephalitis: An Observational Cohort Study, The Lancet. Neurology, vol.12, issue.2, pp.157-65, 2013.

S. E. Tomlinson, G. Michael, D. M. Hanna, S. V. Kullmann, D. Tan et al., Clinical Neurophysiology of the Episodic Ataxias: Insights into Ion Channel Dysfunction in Vivo, Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology, vol.120, issue.10, pp.1768-76, 2009.

. Torres-vega, N. Estefanía, A. Mancheño, V. Cebrián-silla, M. J. Herranz-pérez et al., Netrin-1 Receptor Antibodies in Thymoma-Associated Neuromyotonia with Myasthenia Gravis, Neurology, vol.88, issue.13, pp.1235-1277, 2017.

M. Traka, L. Goutebroze, N. Denisenko, M. Bessa, A. Nifli et al., Association of TAG-1 with Caspr2 Is Essential for the Molecular Organization of Juxtaparanodal Regions of Myelinated Fibers, The Journal of Cell Biology, vol.162, issue.6, pp.1161-72, 2003.

J. S. Trimmer, Subcellular Localization of K+ Channels in Mammalian Brain Neurons: Remarkable Precision in the Midst of Extraordinary Complexity, Neuron, vol.85, issue.2, pp.238-56, 2015.

O. Varea, M. D. Martin-de-saavedra, K. J. Kopeikina, B. Schürmann, H. J. Fleming et al., Synaptic Abnormalities and Cytoplasmic Glutamate Receptor Aggregates in Contactin Associated Protein-like 2/Caspr2 Knockout Neurons, Proceedings of the National Academy of Sciences of the United States of America, vol.112, pp.6176-81, 2015.

A. Vincent, C. Buckley, J. M. Schott, I. Baker, B. Dewar et al., Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encephalitis, Brain: A Journal of Neurology, vol.127, pp.701-713, 2004.

A. Vincent, . Frcpath, R. Sarosh, and . Irani, Caspr2 Antibodies in Patients with Thymomas, Journal of Thoracic Oncology, issue.10, 2010.

A. Vincent, P. Pettingill, R. Pettingill, B. Lang, R. Birch et al., Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia, JAMA Neurology, vol.75, issue.12, pp.1519-1546, 2018.

. Vogt, K. K. Daniel, S. M. Cho, A. Shelton, Z. J. Paul et al., Mouse Cntnap2 and Human CNTNAP2, 2018.

, ASD Alleles Cell Autonomously Regulate PV+ Cortical Interneurons, Cerebral Cortex, vol.28, issue.11, pp.3868-79, 1991.

O. Walusinski and J. Honnorat, Augustin Morvan (1819-1897), a Little-Known Rural Physician and Neurologist, Revue Neurologique, vol.169, issue.1, pp.2-8, 2013.

M. Weiss, Rituximab Therapy for Morvan Syndrome Associated with Myasthenia Gravis, ANNEXES List of publications, vol.46, issue.1, pp.139-179, 2012.

S. Muñiz-castrillo, B. Joubert, and M. Elsensohn, Clinical phenotypes in CASPR2-antibody diseases correlate with distinct HLA associations and immunological features

B. Joubert, M. Saint-martin, and N. Noraz, Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures, JAMA Neurol, vol.73, issue.9, pp.1115-1124, 2016.

B. Joubert, F. Gobert, and L. Thomas, Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis, Neurol Neuroimmunol Neuroinflammation, vol.4, issue.4, p.371, 2017.

E. Torres-vega, N. Mancheño, and A. Cebrián-silla, Netrin1-receptor and Caspr2 antibodies predict thymoma in myasthenic patients with neuromyotonia, Neurology

M. Saint-martin, B. Joubert, V. Pellier-monnin, O. Pascual, N. Noraz et al., Contactin-associated protein-like 2 (CASPR2), a protein of the neurexin family involved in several human diseases, Eur J Neurosci, issue.2, 2018.